MAM
McLean Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $626K | Buy |
3,283
+130
| +4% | +$24.8K | 0.16% | 71 |
|
|
2025
Q1 | $554K | Sell |
3,153
-37
| -1% | -$6.5K | 0.18% | 69 |
|
|
2024
Q4 | $567K | Sell |
3,190
-233
| -7% | -$41.4K | 0.17% | 71 |
|
|
2024
Q3 | $665K | Buy |
3,423
+509
| +17% | +$98.9K | 0.2% | 67 |
|
|
2024
Q2 | $490K | Buy |
2,914
+93
| +3% | +$15.6K | 0.16% | 76 |
|
|
2024
Q1 | $480K | Buy |
2,821
+24
| +0.9% | +$4.08K | 0.16% | 75 |
|
|
2023
Q4 | $454K | Sell |
2,797
-157
| -5% | -$25.5K | 0.17% | 70 |
|
|
2023
Q3 | $440K | Buy |
2,954
+210
| +8% | +$31.3K | 0.18% | 65 |
|
|
2023
Q2 | $370K | Sell |
2,744
-167
| -6% | -$22.5K | 0.15% | 84 |
|
|
2023
Q1 | $464K | Sell |
2,911
-415
| -12% | -$66.1K | 0.19% | 62 |
|
|
2022
Q4 | $538K | Buy |
3,326
+259
| +8% | +$41.9K | 0.18% | 61 |
|
|
2022
Q3 | $426K | Sell |
3,067
-64
| -2% | -$8.89K | 0.16% | 62 |
|
|
2022
Q2 | $478K | Buy |
3,131
+105
| +3% | +$16K | 0.19% | 59 |
|
|
2022
Q1 | $491K | Sell |
3,026
-97
| -3% | -$15.7K | 0.36% | 53 |
|
|
2021
Q4 | $429K | Sell |
3,123
-445
| -12% | -$61.1K | 0.17% | 66 |
|
|
2021
Q3 | $391K | Buy |
3,568
+1,141
| +47% | +$125K | 0.15% | 75 |
|
|
2021
Q2 | $285K | Buy |
2,427
+136
| +6% | +$16K | 0.13% | 80 |
|
|
2021
Q1 | $255K | Buy |
2,291
+85
| +4% | +$9.46K | 0.2% | 82 |
|
|
2020
Q4 | $236K | Buy |
+2,206
| New | +$236K | 0.21% | 77 |
|